OTCMKTS:DRREDDY Dr Reddy's Laboratories (DRREDDY) Stock Price, News & Analysis → Write this ticker symbol down… (From StocksToTrade) (Ad) Free DRREDDY Stock Alerts Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Dr Reddy's Laboratories alerts: Email Address Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. About Dr Reddy's Laboratories Stock (OTCMKTS:DRREDDY)Read More Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. DRREDDY Stock News HeadlinesMay 21, 2024 | markets.businessinsider.comAlvotech Partners Dr. Reddy's To Bring AVT03 Biosimilar To Prolia & Xgeva To U.S., Europe, And U.KMay 7, 2024 | msn.comDr Reddy's Q4 results: Net profit up 36% to Rs 1,307 crore, Rs 40/share dividend declaredMay 7, 2024 | msn.comDr Reddy's Q4 Results: Net profit grows by one-third but misses analyst estimates; drug maker declares dividendApril 25, 2024 | msn.comBanking Stocks Lift Indian Equities HigherApril 4, 2024 | msn.comDr. Reddy’s Laboratories’ subsidiary Aurigene launches AI/ML-assisted drug discovery platformApril 4, 2024 | wsj.comDr. Reddy's Laboratories Ltd. ADRApril 3, 2024 | msn.comIndian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate CutsMarch 19, 2024 | finanznachrichten.deDr. Reddy's Laboratories Ltd.: Dr. Reddy's Laboratories launches Versavo (bevacizumab) in the UKMarch 13, 2024 | msn.comDr Reddy's gets Rs 74.22 cr tax demand with penalty from GST authorityMarch 1, 2024 | msn.comDr Reddy’s Laboratories shares fall 2% on potential antitrust lawsuit in USJanuary 31, 2024 | finanznachrichten.deDr. Reddy's Q3 & 9M FY24 Financial ResultsJanuary 30, 2024 | msn.comDr Reddy’s Labs Q3 Results: Profit rises 11% to Rs 1380.90 crore, revenue up 6.6% on-year; beats estimatesJanuary 30, 2024 | msn.comDr Reddy's Q3 results: Net profit rises 11% to Rs 1,379 crJanuary 30, 2024 | benzinga.comDr Reddy's Laboratories Stock (NYSE:RDY), Guidance and ForecastJanuary 30, 2024 | benzinga.comDr Reddy's Laboratories: Q3 Earnings InsightsJanuary 30, 2024 | msn.comDr. Reddy's GAAP EPS of $0.99, revenue of $867MJanuary 18, 2024 | entrepreneur.comDr. Reddy's Leads Indian Pharma As First Member Of DJSI World Index, Entering 2024 On Strong FootingJanuary 3, 2024 | finance.yahoo.comDr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women’s Health and Dietary Supplements Portfolio of BrandsDecember 11, 2023 | reuters.comIndia's Dr. Reddy's shares fall on observations from US regulatorDecember 11, 2023 | msn.comDr Reddy’s shares fall over 6% today. Here’s whyNovember 29, 2023 | seekingalpha.comDr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising AdvancementsAugust 23, 2023 | msn.comDr. Reddy's: Growth Supported By New Labels, ProfitabilityAugust 10, 2023 | msn.comDr. Reddy's Laboratories Ltd (RDY) Hits Fresh High: Is There Still Room to Run?August 10, 2023 | finance.yahoo.comDr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.August 9, 2023 | msn.comLate Rally Pushes Indian Equities to End Closer on Wednesday; Metal, Oil & Gas Top GainersSee More Headlines Receive DRREDDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:DRREDDY CUSIPN/A CIKN/A WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report DRREDDY Stock Analysis - Frequently Asked Questions How do I buy shares of Dr Reddy's Laboratories? Shares of DRREDDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DRREDDY) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr Reddy's Laboratories Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.